153 related articles for article (PubMed ID: 36628893)
1. Levels of pretreatment serum lipids predict responses to PD-1 inhibitor treatment in advanced intrahepatic cholangiocarcinoma.
Yang Z; Zhang D; Sima X; Fu Y; Zeng H; Hu Z; Hou J; Pan Y; Zhang Y; Zhou Z; Chen M; Hu D
Int Immunopharmacol; 2023 Feb; 115():109687. PubMed ID: 36628893
[TBL] [Abstract][Full Text] [Related]
2. Nomogram for predicting the prognosis of metastatic colorectal cancer patients treated with anti-PD1 therapy based on serum lipids analysis.
Xiao B; Ouyang H; Gulizeba H; Fu H; Wang Z; Huang Y
Cancer Immunol Immunother; 2023 Nov; 72(11):3683-3692. PubMed ID: 37589756
[TBL] [Abstract][Full Text] [Related]
3. Prognostic nomogram integrated baseline serum lipids for patients with non-esophageal squamous cell carcinoma.
Chen S; Li X; Wen X; Peng S; Xue N; Xing S; Liu Y
Ann Transl Med; 2019 Oct; 7(20):548. PubMed ID: 31807530
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma.
Zhang R; Li Q; Fu J; Jin Z; Su J; Zhang J; Chen C; Geng Z; Zhang D
BMC Cancer; 2021 Feb; 21(1):112. PubMed ID: 33535978
[TBL] [Abstract][Full Text] [Related]
5. Incremental value of volumetric multiparametric MRI over Fudan score for prognosis of unresectable intrahepatic cholangiocarcinoma treated with systemic chemotherapy.
Pandey A; Mohseni A; Shaghaghi M; Pandey P; Rezvani Habibabadi R; Hazhirkarzar B; Ly A; Panid Madani S; Borhani A; Kamel IR
Eur J Radiol; 2024 Jan; 170():111196. PubMed ID: 38029705
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of sarcopenia combined with preoperative fibrinogen-albumin ratio in patients with intrahepatic cholangiocarcinoma after surgery: A multicenter, prospective study.
Yu H; Wang M; Wang Y; Yang J; Deng L; Bao W; He B; Lin Z; Chen Z; Chen K; Zhang B; Liu F; Yu Z; Ye L; Jin B; Chen G
Cancer Med; 2021 Jul; 10(14):4768-4780. PubMed ID: 34105304
[TBL] [Abstract][Full Text] [Related]
7. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
[No Abstract] [Full Text] [Related]
8. The Integrated Prediction of Clinical and Pathological Factors on the Prognosis of Intrahepatic Cholangiocarcinoma.
Chen G; Li S; Xia A; Xing Y; Liang W
Am Surg; 2024 Jun; 90(6):1481-1490. PubMed ID: 38549438
[TBL] [Abstract][Full Text] [Related]
9. A novel prognostic system combining carbonic anhydrase II and preoperative CA19-9 for intrahepatic cholangiocarcinoma after curative resection.
Zhang J; Huang Q; Yang Y; Zhang J; Fang X; Yang Y; Liang H; Wang W; Wang Y
Cancer; 2023 Apr; 129(7):1030-1040. PubMed ID: 36625486
[TBL] [Abstract][Full Text] [Related]
10. A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma.
Zou W; Wang Z; Wang F; Li L; Liu R; Hu M
BMC Cancer; 2021 May; 21(1):608. PubMed ID: 34034689
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of sarcopenia combined with hepatolithiasis in intrahepatic cholangiocarcinoma patients after surgery: A prospective cohort study.
Deng L; Wang Y; Zhao J; Tong Y; Zhang S; Jin C; Chen K; Bao W; Yu Z; Chen G
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):603-612. PubMed ID: 32933804
[TBL] [Abstract][Full Text] [Related]
12. [A novel nomogram for individualized preoperative prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma].
Ma WH; Lei ZQ; Yu QS; Xiao QR; Tang HL; Si AF; Yang PH; Cheng ZJ
Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):363-371. PubMed ID: 35272428
[No Abstract] [Full Text] [Related]
13. CT-based clinico-radiological nomograms for prognosis prediction in patients with intrahepatic mass-forming cholangiocarcinoma: a multi-institutional study.
Jiao CY; Zhang H; Ji GW; Xu Q; Lu M; Zhang B; Yang Y; Wang XH; Li XC
Eur Radiol; 2022 Dec; 32(12):8326-8338. PubMed ID: 35708837
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study.
Zhu C; Li H; Yang X; Wang S; Wang Y; Zhang N; Wang Y; Xue J; Zhang L; Ning C; Yang X; Xun Z; Chao J; Long J; Sang X; Zhu Z; Zhao H
Cancer Immunol Immunother; 2023 Sep; 72(9):2949-2960. PubMed ID: 37247023
[TBL] [Abstract][Full Text] [Related]
15. Alpha-L-Fucosidase Serves as a Prognostic Indicator for Intrahepatic Cholangiocarcinoma and Inhibits Its Invasion Capacity.
Shuang Z; Mao Y; Lin G; Wang J; Huang X; Chen J; Duan F; Li S
Biomed Res Int; 2018; 2018():8182575. PubMed ID: 29682557
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of sarcomatoid change in patients with intrahepatic cholangiocarcinoma and prognosis after surgical liver resection: A Propensity Score Matching analysis.
Wang T; Kong J; Yang X; Shen S; Zhang M; Wang W
J Surg Oncol; 2020 Mar; 121(3):524-537. PubMed ID: 31867746
[TBL] [Abstract][Full Text] [Related]
17. Inflammation-Based Scores Predict Responses to PD-1 Inhibitor Treatment in Intrahepatic Cholangiocarcinoma.
Yang Z; Zhang D; Zeng H; Fu Y; Hu Z; Pan Y; Chen J; Wang J; Zhang Y; Zhou Z; Xu L; Hu D; Chen M
J Inflamm Res; 2022; 15():5721-5731. PubMed ID: 36238770
[TBL] [Abstract][Full Text] [Related]
18. Hemoglobin and Neutrophil Count as Prognostic Factors in Cholangiocarcinoma Patients in 2nd Line Treatment Setting: Results from a Small Monocentric Retrospective Study.
Liguori C; Copparoni C; Felicetti C; Pecci F; Lupi A; Pinterpe G; Berardi R; Giampieri R
Curr Oncol; 2023 Jan; 30(1):1032-1045. PubMed ID: 36661728
[TBL] [Abstract][Full Text] [Related]
19. [The analysis of long-term prognostic factors after laparoscopic liver resection for intrahepatic cholangiocarcinoma and establishment of survival Nomogram model].
Shen ZF; Chen C; Geng ZM; Mao XH; Li JD; Song TQ; Sun CD; Wu H; Cheng ZJ; Lin RX; He Y; Zhai WL; Tang D; Tang ZH; Liang X
Zhonghua Wai Ke Za Zhi; 2022 Oct; 60(10):939-947. PubMed ID: 36207983
[No Abstract] [Full Text] [Related]
20. Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection.
Li XH; Zhao CY; Zhou EL; Lin XJ
BMC Cancer; 2022 Nov; 22(1):1159. PubMed ID: 36357848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
